These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 28366074)

  • 1. Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema.
    Güler E; Totan Y; Betül Güragaç F
    Cutan Ocul Toxicol; 2017 Jun; 36(2):180-184. PubMed ID: 28366074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.
    Kim M; Cho YJ; Lee CH; Lee SC
    Eye (Lond); 2016 May; 30(5):718-25. PubMed ID: 26939558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The additive effect of intravitreal dexamethasone combined with bevacizumab in refractory diabetic macular edema.
    Karimi S; Karrabi N; Hassanpour K; Amirabadi A; Daneshvar K; Nouri H; Abtahi SH
    J Fr Ophtalmol; 2023 Nov; 46(9):1019-1029. PubMed ID: 37481454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
    Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
    Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-VEGF versus dexamethasone implant (Ozurdex) for the management of Centre involved Diabetic Macular Edema (CiDME): a randomized study.
    Sharma A; Bellala K; Dongre P; Reddy P
    Int Ophthalmol; 2020 Jan; 40(1):67-72. PubMed ID: 31377905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion.
    Kim M; Lee DH; Byeon SH; Koh HJ; Kim SS; Lee SC
    Br J Ophthalmol; 2015 Sep; 99(9):1271-6. PubMed ID: 25777815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
    Lim JW; Lee HK; Shin MC
    Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU; Harless A; Bleau L; Maturi RK
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
    He Y; Ren XJ; Hu BJ; Lam WC; Li XR
    BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Diclofenac plus Bevacizumab versus Bevacizumab alone in treatment-naive diabetic macular edema: a randomized double-blind clinical trial.
    Ghanbari H; Kianersi F; Sonbolestan SA; Abtahi MA; Akbari M; Abtahi ZA; Abtahi SH
    Int Ophthalmol; 2017 Aug; 37(4):867-874. PubMed ID: 27624173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial.
    Mehta H; Fraser-Bell S; Nguyen V; Lim LL; Gillies MC
    Ophthalmol Retina; 2018 Mar; 2(3):231-234. PubMed ID: 31047591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
    Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
    Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.